Tuesday, November 5, 2024

Artificial Intelligence news

This AI-generated Minecraft may...

When you walk around in a version of the video game Minecraft...

OpenAI brings a new...

ChatGPT can now search the web for up-to-date answers to a user’s...

Chasing AI’s value in...

Inspired by an unprecedented opportunity, the life sciences sector has gone all...

Cultivating the next generation...

A few years ago, I had to make one of the biggest...
HomeNewsAI builds momentum...

AI builds momentum for smarter health care


The pharmaceutical industry operates under one of the highest failure rates of any business sector. The success rate for drug candidates entering capital Phase 1 trials—the earliest type of clinical testing, which can take 6 to 7 years—is anywhere between 9% and 12%, depending on the year, with costs to bring a drug from discovery to market ranging from $1.5 billion to $2.5 billion, according to Science.

This skewed balance sheet drives the pharmaceutical industry’s search for machine learning (ML) and AI solutions. The industry lags behind many other sectors in digitization and adopting AI, but the cost of failure—estimated at 60% of all R&D costs, according to Drug Discovery Today—is an important driver for companies looking to use technology to get drugs to market, says Vipin Gopal, former chief data and analytics officer at pharmaceutical giant Eli Lilly, currently serving a similar role at another Fortune 20 company.

“All of these drugs fail due to certain reasons—they do not meet the criteria that we expected them to meet along some points in that clinical trial cycle,” he says. “What if we could identify them earlier, without having to go through multiple phases of clinical trials and then discover, ‘Hey, that doesn’t work.’”

The speed and accuracy of AI can give researchers the ability to quickly identify what will work and what will not, Gopal says. “That’s where the large AI computational models could help predict properties of molecules to a high level of accuracy—to discover molecules that might not otherwise be considered, and to weed out those molecules that, we’ve seen, eventually do not succeed,” he says.

Download the full report.

This content was produced by Insights, the custom content arm of MIT Technology Review. It was not written by MIT Technology Review’s editorial staff.



Article Source link and Credit

Continue reading

Palmer Luckey’s vision for the future of mixed reality

This story originally appeared in The Algorithm, our weekly newsletter on AI. To get stories like this in your inbox first, sign up here. War is a catalyst for change, an expert in AI and warfare told me in...

AI will add to the e-waste problem. Here’s what we can do about it.

Generative AI could account for up to 5 million metric tons of e-waste by 2030, according to a new study. That’s a relatively small fraction of the current global total of over 60 million metric tons of e-waste each...

This AI system makes human tutors better at teaching children math

The US has a major problem with education inequality. Children from low-income families are less likely to receive high-quality education, partly because poorer districts struggle to retain experienced teachers.  Artificial intelligence could help, by improving the one-on-one tutoring sometimes...